Final report |
PDF-file (9,5 Mb)
The links to the final reports (and other publications) of each
sub-project can be selected separately from the list of
Projects
Summary
HERMO (Health Risk Assessment of Mobile Communications) was the fourth one
in a series of national research programmes in Finland since 1994. These
programmes, held by Finnish universities and research centres have aimed to
answer the needs of people and to support international projects in the area
of health effects of electromagnetic fields. The planning of the HERMO
programme was based on the research needs listed in the WHO Research Agenda
and review of recent literature.
The aims of the HERMO research programme were:
- to study acute and chronic effects of RF fields on the nervous system
and sensory organs
- to investigate the effects of RF fields on children
- to study the sources of error in an epidemiological study on mobile
phone use and cancer
- to improve dosimetry and to provide dosimetric support for biological
studies of this project
- to study the dosimetry of RF fields near metallic implants
- to provide materials for risk communication on RF fields
- to study the biological relevance of amplitude modulation
No evidence of detrimental health effects were obtained in the studies on
cell cultures, laboratory animals, voluntary persons, or theoretical
modelling. Some interesting biological effects were found, however.
The programme was coordinated by the University of Kuopio. The other
participants responsible of the 13 sub-projects were University of Turku,
University of Helsinki, Finnish Institute of Occupational Health, Tampere
University of Technology, STUK Radiation and Nuclear Safety Authority, and
VTT Technical Research Centre of Finland.
The total costs of the programme were about 1,9 million euros, of which
over 80 % were covered by governmental sources and the rest by mobile phone
manufacturers and network operators: Tekes- Finnish Funding Agency for
Technology and Innovation (46 %). Universities and research institutes (37 %)
Nokia, Sonera, Elisa and Finnet (17 %).
| HERMO - Health Risk Assessment of Mobile Communications | Päivitetty
30.11.2007 | |